We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
EPS 컨센서스 3.05 · 매출 컨센서스 253.2억. 발표 후 실제치와 비교하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $269.95 · 22 analysts
Stored first · Google News · Yahoo Finance (English)
JNJ Vs. KO: Which Dividend Stock Is The Better Buy?
Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says
Johnson & Johnson (JNJ) call put ratio 2.8 calls to 1 put into quarter results - StreetInsider
Johnson & Johnson (JNJ) call put ratio 2.8 calls to 1 put into quarter results StreetInsider
Royal Bank Of Canada Raises Johnson & Johnson (NYSE:JNJ) Price Target to $287.00 - MarketBeat
Royal Bank Of Canada Raises Johnson & Johnson (NYSE:JNJ) Price Target to $287.00 MarketBeat
Is JNJ Stock a Buy, Sell or Hold Ahead of Q2 Earnings Release?
TD Cowen Adjusts Price Target on Johnson & Johnson to $300 From $250, Maintains Buy Rating
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 10. 13. | After market close (AMC) | $3.05 | — | — | $25.32B | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 07. 17. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 07. 17. | Raymond James | — | Maintain | Outperform → Outperform | — | Raymond James: Outperform |
| 2026. 07. 17. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 07. 16. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 07. 16. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 07. 14. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
Price data
No holdings data to show.